首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1485739

活生物治療產品和微生物 CDMO 市場，依服務類型、營運規模、應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Live Biotherapeutics Products & Microbe CDMO Market, By Service Type, By Scale of Operation, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年05月11日 | 出版商:

AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023 年，活體生物治療產品和微生物 CDMO 市場規模為 2,034 萬美元，2024 年至 2032 年複合年成長率為 40.5%。

活體生物治療產品與微生物 CDMO 市場-市場動態

推動下一代活性生物療法和微生物組契約製造的研發計劃

推動下一代活體生物療法和微生物組契約製造的研發計畫正在重塑治療發展。例如，美國國立衛生研究院 (NIH) 為微生物組研究分配了大量資金，強調了其在醫療保健創新中的重要性。此外，Seres Therapeutics 和 Vedanta Biosciences 等領先的生物製藥公司正在開拓新型活生物治療候選藥物，強調基於微生物組的療法的潛力。學術機構和 CDMO 之間的合作，例如加州大學聖地牙哥分校與 SGI-DNA 之間在合成生物學解決方案方面的合作，展示了先進技術在以微生物組為中心的製造中的日益整合。這些努力強調了向具有廣泛臨床意義的個人化、微生物組標靶治療的變革性轉變。

活體生物療法產品和微生物 CDMO 市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 40.5% 左右的複合年成長率成長

根據服務類型區隔，預計製造服務將在 2023 年顯示最大的市場佔有率

根據手術規模區隔，臨床規模手術是2023年的主導類型

依地區分類，北美是 2023 年的主要收入來源

活體生物治療產品與微生物 CDMO 市場-區隔分析：

全球活體生物治療產品和微生物 CDMO 市場根據服務類型、營運規模、應用和區域進行區隔。

根據服務類型，市場分為兩類：開發服務和製造服務。由於生產活性生物治療產品對專業製造能力的迫切需求，消費者通常優先考慮製造服務而不是開發服務。高效且可擴展的製造流程對於基於微生物組的療法的商業化和市場供應至關重要。

根據營運規模，市場分為三類：臨床前規模營運、臨床規模營運和商業規模營運。營運通常優先考慮臨床規模營運，其次是商業規模營運，然後是臨床前規模營運。臨床規模營運對於推動產品開發走向法規核准和商業化至關重要，而商業規模運作則確保活體生物治療藥物的市場供應和可擴展性。

活體生物治療產品和微生物 CDMO 市場 - 地理洞察

由於領先的製藥和生物技術公司強勁的研發活動和對基於微生物組的療法的投資，北美佔據了顯著的地位。歐洲緊隨其後，建立了支持活體生物治療和 CDMO 服務創新的監管框架。亞太地區展現出快速成長潛力，這歸因於醫療保健支出的增加、先進生物技術的不斷採用以及本地和國際參與者之間不斷成長的合作夥伴關係。該地區的新興經濟體，特別是中國和印度等國家，正在見證以微生物組為重點的研究和開發的激增，從而促進了市場的擴張。

活生物治療產品與微生物 CDMO 市場-競爭格局：

Lonza Group、Charles River Laboratories 和 Catalent 等主要參與者處於領先地位，為活性生物治療藥物的開發和製造提供全面的 CDMO 服務。 Seres Therapeutics 和 Vedanta Biosciences 在活體生物治療產品領域處於領先地位，專注於針對各種適應症的基於微生物組的療法。 Bacteria 和 Seres Therapeutics 等商業製造領域的合作凸顯了透過合作來增強製造能力和擴大市場覆蓋範圍的趨勢。 SBT Instruments 等新興公司貢獻創新技術，而老牌企業則投資研發，重新定義以微生物組為中心的療法和合約製造服務的未來。這種競爭格局凸顯了我們不斷努力推動創新並滿足對先進活性生物療法產品和 CDMO 解決方案不斷成長的需求。多家公司正在合作開發和生產創新的活體生物治療藥物。例如，2019 年 10 月，4D Pharma plc 宣布與默沙東、默克公司達成研究合作和授權協議，以發現和開發用於疫苗的活生物治療產品 (LBP)。

市場片段
- 依服務類型分類的活生物治療產品和微生物 CDMO 市場片段
- 依營運規模分類的活體生物療法產品和微生物 CDMO 市場片段
- 活生物治療產品和微生物 CDMO 市場片段（依應用）
- 依國家/地區分類的活生物治療產品和微生物 CDMO 市場片段
- 依地區分類的活生物療法產品和微生物 CDMO 市場片段
競爭洞察

第 3 章：活生物治療產品和微生物 CDMO 主要市場趨勢

活生物治療產品和微生物 CDMO 市場促進因素
- 市場促進因素的影響分析
活體生物治療產品和微生物 CDMO 市場限制
- 市場限制影響分析
活體生物治療產品和微生物 CDMO 市場機會
活體生物治療產品與微生物 CDMO 市場未來趨勢

第 4 章：活生物治療產品與微生物 CDMO 產業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第 5 章：活生物治療產品與微生物 CDMO 市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第 6 章：活體生物療法產品與微生物 CDMO 市場格局

活體生物療法產品和微生物 CDMO 市場佔有率分析，2023 年
依主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析

第 7 章：活生物治療產品和微生物 CDMO 市場 - 依服務類型

概述
- 依服務類型分類的區隔市場佔有率分析
- 開發服務
- 製造服務
- 其他

第 8 章：活生物治療產品和微生物 CDMO 市場 - 依營運規模

概述
- 依經營規模分類的區隔市場佔有率分析
- 臨床前規模營運
- 臨床規模營運
- 商業規模營運

第 9 章：活體生物療法產品和微生物 CDMO 市場 - 依應用

概述
- 依應用分類的區隔市場佔有率分析
- 艱難梭菌
- 克隆氏症
- 腸躁症
- 糖尿病
- 其他

第 10 章：活生物治療產品和微生物 CDMO 市場 - 依地理位置

介紹
- 依地理位置分類的區隔市場佔有率分析
北美洲
- 概述
- 北美活體生物療法產品和微生物 CDMO 主要製造商
- 北美市場規模和預測（依國家）
- 北美市場規模和預測（依服務類型）
- 北美市場規模和預測（依營運規模）
- 北美市場規模和預測（依應用）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲活體生物治療產品和微生物 CDMO 主要製造商
- 歐洲市場規模和預測（依國家）
- 歐洲市場規模和預測（依服務類型）
- 歐洲市場規模與預測（依營運規模）
- 歐洲市場規模和預測（依應用）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區活體生物療法產品和微生物 CDMO 主要製造商
- 亞太地區市場規模與預測（依國家）
- 亞太地區市場規模與預測（依服務類型）
- 依營運規模分類的亞太市場規模和預測
- 亞太地區市場規模與預測（依應用）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲活體生物治療產品和微生物 CDMO 主要製造商
- 拉丁美洲市場規模與預測（依國家）
- 拉丁美洲市場規模和預測（依服務類型）
- 拉丁美洲市場規模與預測（依營運規模）
- 拉丁美洲市場規模與預測（依應用）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲活體生物療法產品和微生物 CDMO 主要製造商
- 中東和非洲市場規模及預測（依國家）
- 中東和非洲市場規模及預測（依服務類型）
- 中東和非洲市場規模及預測（依營運規模）
- 中東和非洲市場規模及預測（依應用）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 活體生物治療產品和微生物 CDMO 產業

競爭儀表板
公司簡介
- D Pharma PLC
- Catalent, Inc.
- Chr. Hansen Holding A/S
- Evelo Biosciences, Inc.
- Evonik Industries AG
- Ferring Pharmaceuticals
- Lonza Group AG
- Microbiotica Ltd.
- Pivot Bio
- Rebiotix, Inc. (a Ferring Pharmaceuticals company)
- Samsung Biologics
- Second Genome, Inc.
- Seres Therapeutics, Inc.
- Synlogic, Inc.
- Vedanta Biosciences, Inc.
- Wacker Chemie AG
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2637

REPORT HIGHLIGHT

Live Biotherapeutics Products & Microbe CDMO Market size was valued at USD 20.34 million in 2023, expanding at a CAGR of 40.5% from 2024 to 2032.

The Live Biotherapeutics Products & Microbe CDMO market involves developing, manufacturing, and commercializing therapeutic products based on live microbes for medical applications. The increasing demand for microbiome-based therapies is driven by awareness of the microbiome's role in health, advancements in microbial engineering enabling customized therapeutics, and the rising prevalence of chronic diseases facilitating market entry. However, challenges such as the complexity of microbiome research, manufacturing scalability issues, safety concerns, and limited market understanding pose restraints on market growth. Opportunities lie in expanding therapeutic applications beyond gastrointestinal disorders, increased R&D investment in microbiome therapeutics, and personalized medicine approaches enhancing targeted treatment strategies in healthcare.

Live Biotherapeutics Products & Microbe CDMO Market- Market Dynamics

Advancing R&D Initiatives in Next-Generation Live Biotherapeutics and Microbiome Contract Manufacturing

Advancing R&D initiatives in next-generation live biotherapeutics and microbiome contract manufacturing are reshaping therapeutic development. For instance, the National Institutes of Health (NIH) has allocated significant funding towards microbiome research, highlighting its importance in healthcare innovation. Additionally, leading biopharmaceutical companies like Seres Therapeutics and Vedanta Biosciences are pioneering novel live biotherapeutic candidates, emphasizing the potential of microbiome-based therapies. Collaborations between academic institutions and CDMOs, such as the partnership between the University of California, San Diego, and SGI-DNA for synthetic biology solutions, showcase the growing integration of advanced technologies in microbiome-focused manufacturing. These efforts underscore a transformative shift towards personalized, microbiome-targeted therapeutics with broad clinical implications.

Live Biotherapeutics Products & Microbe CDMO Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.5% over the forecast period (2024-2032)

Based on Service Type segmentation, Manufacturing Services was predicted to show maximum market share in the year 2023

Based on the Scale of Operation segmentation, Clinical Scale Operations was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Live Biotherapeutics Products & Microbe CDMO Market- Segmentation Analysis:

The Global Live Biotherapeutics Products & Microbe CDMO Market is segmented based on Service Type, Scale of Operation, Application, and Region.

The market is divided into two categories based on Service Type: Development Services and Manufacturing Services. Consumers typically prioritize Manufacturing Services over Development Services due to the critical need for specialized manufacturing capabilities in producing live biotherapeutic products. Efficient and scalable manufacturing processes are essential for the commercialization and market supply of microbiome-based therapies.

The market is divided into three categories based on Scale of Operation: Preclinical Scale Operations, Clinical Scale Operations, and Commercial Scale Operations. Operations typically prioritize Clinical Scale Operations followed by Commercial Scale Operations and then Preclinical Scale Operations. Clinical scale operations are critical for advancing product development towards regulatory approval and commercialization, while commercial scale operations ensure market supply and scalability of live biotherapeutics.

Live Biotherapeutics Products & Microbe CDMO Market- Geographical Insights

North America holds a prominent position, driven by robust R&D activities and investments in microbiome-based therapies by leading pharmaceutical and biotechnology companies. Europe follows closely, with established regulatory frameworks supporting innovation in live biotherapeutics and CDMO services. Asia Pacific showcases rapid growth potential, attributed to increasing healthcare expenditure, rising adoption of advanced biotechnology, and growing partnerships between local and international players. Emerging economies in this region, particularly in countries like China and India, are witnessing a surge in microbiome-focused research and development, contributing to market expansion.

Live Biotherapeutics Products & Microbe CDMO Market- Competitive Landscape:

Key players like Lonza Group, Charles River Laboratories, and Catalent are at the forefront, offering comprehensive CDMO services for live biotherapeutics development and manufacturing. Seres Therapeutics and Vedanta Biosciences lead in live biotherapeutics products, focusing on microbiome-based therapies for various indications. Collaborations such as Bacteria and Seres Therapeutics for commercial manufacturing highlight the trend towards partnerships to enhance manufacturing capabilities and expand market reach. Emerging companies like SBT Instruments contribute innovative technologies, while established players invest in R&D to redefine the future of microbiome-focused therapies and contract manufacturing services. This competitive landscape underscores ongoing efforts to drive innovation and meet the growing demand for advanced live biotherapeutic products and CDMO solutions. Several companies are collaborating for the development and production of innovative live biotherapeutics. For instance, in October 2019, 4D Pharma plc announced a research collaboration and licensing agreement with MSD, Merck & Co., Inc., to discover and develop Live Biotherapeutic Products (LBPs) for vaccines.

Recent Developments:

In June 2023, Biose Industrie and SBT Instruments collaborated to integrate rapid viable cell counts into Biose's manufacturing, setting a new standard for microbe enumeration. This integration aims to expedite clinical trials and market approval for Biose's live biotherapeutic products.

In November 2021, Bacthera and Seres Therapeutics are collaborating to manufacture SER-109, Seres' lead product candidate for recurrent Clostridioides difficile infection (CDI). Bacthera is establishing a dedicated commercial manufacturing facility within its new Microbiome Center of Excellence located on Lonza's Ibex campus in Visp, Switzerland.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

4D Pharma PLC

Catalent, Inc.

Chr. Hansen Holding A/S

Evelo Biosciences, Inc.

Evonik Industries AG

Ferring Pharmaceuticals

Lonza Group AG

Microbiotica Ltd.

Pivot Bio

Rebiotix, Inc. (a Ferring Pharmaceuticals company)

Samsung Biologics

Second Genome, Inc.

Seres Therapeutics, Inc.

Synlogic, Inc.

Vedanta Biosciences, Inc.

Wacker Chemie AG

Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Development Services
Manufacturing Services
Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SCALE OF OPERATION- MARKET ANALYSIS, 2019 - 2032

Preclinical Scale Operations
Clinical Scale Operations
Commercial Scale Operations

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

C.difficle
Crohn's disease
IBS
Diabetes
Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Live Biotherapeutics Products & Microbe CDMO Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Service Type
- 2.1.2.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Scale of Operation
- 2.1.3.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Application
- 2.1.4.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Country
- 2.1.5.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Region
2.2.Competitive Insights

3.Live Biotherapeutics Products & Microbe CDMO Key Market Trends

3.1.Live Biotherapeutics Products & Microbe CDMO Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Live Biotherapeutics Products & Microbe CDMO Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Live Biotherapeutics Products & Microbe CDMO Market Opportunities
3.4.Live Biotherapeutics Products & Microbe CDMO Market Future Trends

4.Live Biotherapeutics Products & Microbe CDMO Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Live Biotherapeutics Products & Microbe CDMO Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Live Biotherapeutics Products & Microbe CDMO Market Landscape

6.1.Live Biotherapeutics Products & Microbe CDMO Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Live Biotherapeutics Products & Microbe CDMO Market - By Service Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 7.1.2.Development Services
- 7.1.3.Manufacturing Services
- 7.1.4.Others

8.Live Biotherapeutics Products & Microbe CDMO Market - By Scale of Operation

8.1.Overview
- 8.1.1.Segment Share Analysis, By Scale of Operation, 2023 & 2032 (%)
- 8.1.2.Preclinical Scale Operations
- 8.1.3.Clinical Scale Operations
- 8.1.4.Commercial Scale Operations

9.Live Biotherapeutics Products & Microbe CDMO Market - By Application

9.1.Overview
- 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2.C.difficle
- 9.1.3.Crohns disease
- 9.1.4.IBS
- 9.1.5.Diabetes
- 9.1.6.Others

10.Live Biotherapeutics Products & Microbe CDMO Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Live Biotherapeutics Products & Microbe CDMO Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.4D Pharma PLC
- 11.2.2.Catalent, Inc.
- 11.2.3.Chr. Hansen Holding A/S
- 11.2.4.Evelo Biosciences, Inc.
- 11.2.5.Evonik Industries AG
- 11.2.6.Ferring Pharmaceuticals
- 11.2.7.Lonza Group AG
- 11.2.8.Microbiotica Ltd.
- 11.2.9.Pivot Bio
- 11.2.10.Rebiotix, Inc. (a Ferring Pharmaceuticals company)
- 11.2.11.Samsung Biologics
- 11.2.12.Second Genome, Inc.
- 11.2.13.Seres Therapeutics, Inc.
- 11.2.14.Synlogic, Inc.
- 11.2.15.Vedanta Biosciences, Inc.
- 11.2.16.Wacker Chemie AG
- 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

13.1.Research Methodology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Service Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Service Type
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Service Type 2019-2032 (USD Million)
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Scale of Operation Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Scale of Operation
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation 2019-2032 (USD Million)
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Application 2019-2032 (USD Million)
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Region 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)